ECL vs IDXX vs BMI Stock Comparison

Ecolab, Idexx Laboratories and Badger Meter Prices as of Nov 13, 2026 Peers: Industry group
ECL Ecolab Inc.
$309.20 +7.4% 1M +18.0% 1Y
Market cap
$86.18B
P/E
41.4x
Revenue (TTM)
$17.37B
Div. yield
0.01%
Water Treatment Industrials
3 wins
BMI Badger Meter Inc
$154.79 +20.5% 1M -12.9% 1Y
Market cap
$4.59B
P/E
36.2x
Revenue (TTM)
$881.24M
Div. yield
0.01%
Water Treatment Industrials
4 wins

Head to Head

12 decided of 12

Idexx Laboratories leads on 5 of the 12 questions below (Idexx Laboratories 5, Badger Meter 4, Ecolab 3). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionECLIDXXBMILeader
Larger companyMarket capitalisation $86.18B $55.47B $4.59B ECL
Cheaper on earningsLower P/E, profitable companies only 41.4x 46.9x 36.2x BMI
Cheaper on forward earningsLower price / next fiscal year consensus EPS 39.1x 44.6x 32.7x BMI
Faster revenue growthRevenue growth, trailing twelve months +9.3% +11.9% -2.2% IDXX
More profitableNet margin, trailing twelve months 12.0% 25.4% 14.4% IDXX
Better return on capitalReturn on invested capital 10.0% 45.4% — IDXX
Less leveragedLower net debt / EBITDA 4.0x 0.4x — IDXX
Higher dividend yieldTrailing dividend yield 0.01% 0.00% 0.01% BMI
Better 1-year returnPrice return, last 12 months +18.0% +0.4% -12.9% ECL
Better 5-year returnAnnualised price return, 5 years +5.6%/yr +2.3%/yr +7.2%/yr BMI
Less volatileAnnualised volatility, 1 year 21.8% 36.2% 50.9% ECL
Higher overall scoreMean of the five percentile scores vs peers 60/100 76/100 74/100 IDXX

Percentile Scorecard

ECLIDXXBMI

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisECLIDXXBMI
Valuation 47 #11 of 20 74 #175 of 660 63 #8 of 20
Growth 82 #4 of 18 70 #184 of 619 59 #8 of 18
Profitability 88 #3 of 17 98 #12 of 595 94 #2 of 17
Financial Health 15 #18 of 21 46 #371 of 683 70 #7 of 21
Shareholder Returns 67 #5 of 13 94 #30 of 459 83 #3 of 13
Overall 60 76 74
  • ECL ranked among 21 companies in Environmental Equipment
  • IDXX ranked among 695 companies in Pharmaceuticals and Biotechnology
  • BMI ranked among 21 companies in Environmental Equipment

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodECLIDXXBMISPY
1 month +7.4%+33.1%+20.5% -2.0%
3 months +12.0%+27.8%+18.3% -2.8%
6 months +24.9%+33.2%+35.5% +2.0%
Year to date +17.8%+4.1%-11.2% +10.6%
1 year +18.0%+0.4%-12.9% +12.2%
3 years +68.2%+55.0%+2.9% +68.1%
3 years, per year +18.9%+15.7%+1.0% +18.9%
5 years +31.2%+12.1%+41.5% +61.4%
5 years, per year +5.6%+2.3%+7.2% +10.1%
10 years +167.3%+545.1%+333.6% +248.5%
10 years, per year +10.3%+20.5%+15.8% +13.3%

Risk

MeasureECLIDXXBMISPY
Volatility, 1Y 21.8%36.2%50.9% 13.6%
Downside volatility, 1Y 20.8%32.6%56.4% 13.9%
Beta vs S&P 500, 1Y 0.510.840.65 1.00
Return / volatility, 1Y 0.830.01-0.25 0.90
Max drawdown, 5Y -44.3%-50.9%-55.4% -25.4%
From 52-week high -1.9%-8.1%-16.2% -3.2%
52-week high $315.10$766.68$184.80 $779.14
52-week low $245.73$504.70$113.41 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleECLIDXXBMI
P/E now vs peer median 41.6xmedian 35.2x 47.0xmedian 17.0x 35.2xmedian 35.2x
P/S now vs peer median 5.0xmedian 2.8x 11.9xmedian 8.4x 5.0xmedian 2.8x
EV/EBITDA now vs peer median 32.0xmedian 21.6x 33.7xmedian 14.6x 21.4xmedian 21.6x
P/FCF now vs peer median 48.3xmedian 26.3x 42.6xmedian 19.0x 31.1xmedian 26.3x
P/B now vs peer median 8.3xmedian 2.0x 29.7xmedian 2.0x 6.8xmedian 2.0x
PEG now vs peer median 2.10median 2.10 3.10median 0.43 2.38median 2.10

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsECLIDXXBMI
Revenue $17.37B $4.66B $881.24M
Gross profit $7.63B $2.92B $366.94M
Operating income $2.90B $1.51B $165.34M
Net income $2.10B $1.18B $126.53M
Free cash flow $1.80B $1.30B $142.39M
R&D – $266.87M –
EPS (diluted) $7.38 $14.96 $4.38
Cash & equivalents $722.30M $197.54M $67.93M
Total debt $13.19B $848.88M –
Shares (diluted) 282.10M 79.05M 28.87M
Enterprise value $79.16B $54.69B $3.99B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricECLIDXXBMI
P/E 41.6x 47.0x 35.2x
P/FCF 48.3x 42.6x 31.1x
P/Operating cash flow 28.6x 39.1x 27.9x
P/S 5.0x 11.9x 5.0x
P/B 8.3x 29.7x 6.8x
P/Tangible book 16.2x 31.7x 9.0x
EV/EBITDA 32.0x 33.7x 21.4x
EV/EBIT 34.2x 37.3x 26.3x
EV/Revenue 5.7x 12.0x 4.9x
EV/FCF 55.3x 43.1x 30.6x
EV/Operating cash flow 32.7x 39.6x 27.4x
PEG (3Y EPS CAGR) 2.10 3.10 2.38

Growth

14 metrics
MetricECLIDXXBMI
Revenue growth (1Y) 9.3% 11.9% -2.2%
Revenue CAGR (3Y) 4.9% 9.1% 9.6%
Gross profit growth (1Y) 8.4% 13.7% -1.3%
Gross profit CAGR (3Y) 8.8% 10.8% 11.9%
Operating income growth (1Y) 11.3% 15.3% -7.9%
Operating income CAGR (3Y) 17.2% 11.8% 15.1%
Net income growth (1Y) 4.7% 15.1% -8.8%
Net income CAGR (3Y) 18.8% 12.8% 14.0%
EPS growth (1Y) 6.2% 17.4% -6.6%
EPS CAGR (3Y) 19.8% 15.1% 14.8%
Operating cash flow growth (1Y) 15.2% 30.4% -12.3%
Operating cash flow CAGR (3Y) 7.8% 19.6% 15.9%
Free cash flow growth (1Y) 15.6% 35.3% -14.4%
Free cash flow CAGR (3Y) 1.8% 24.2% 16.2%

Profitability

14 metrics
MetricECLIDXXBMI
Gross margin 43.9% 62.7% 41.6%
EBITDA margin 17.8% 35.7% 23.1%
Operating margin 16.7% 32.3% 18.8%
Pretax margin 15.0% 31.7% 19.1%
Net margin 12.0% 25.4% 14.4%
FCF margin 10.3% 28.0% 16.2%
Operating cash flow margin 17.4% 30.4% 18.0%
Return on equity 20.4% 67.9% 19.0%
Return on assets 6.9% 33.1% 13.0%
Return on invested capital 10.0% 45.4% –
Return on capital employed 12.0% 65.2% 20.1%
Asset turnover 0.6x 1.3x 0.9x
Cash conversion (OCF / net income) 1.4x 1.2x 1.3x
Stock comp / revenue 0.8% 1.4% 1.2%

Financial Health

11 metrics
MetricECLIDXXBMI
Debt / assets 42.4% 22.9% –
Debt / equity 1.3x 0.5x –
Net debt / EBITDA 4.0x 0.4x –
Debt / FCF 7.3x 0.7x –
Liabilities / assets 66.4% 49.6% 31.0%
Equity / assets 33.6% 50.4% 69.0%
Interest coverage 8.0x 43.5x –
Current ratio 1.1x 1.2x 2.5x
Quick ratio 0.7x 0.7x 1.2x
Cash ratio 0.1x 0.2x 0.5x
Altman Z-score 4.03 23.56 11.90

Shareholder Returns

7 metrics
MetricECLIDXXBMI
Dividend yield 0.9% – 1.1%
Net buyback yield 1.1% 1.7% 2.7%
Shareholder yield 2.0% 1.7% 3.7%
Payout ratio (earnings) 39.0% – 37.7%
Payout ratio (FCF) 45.6% – 33.5%
Dividend growth (1Y) 12.7% – 14.1%
Dividend CAGR (3Y) 9.7% – 19.8%

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusECLIDXXBMI
Forward P/E 39.1xFY2026 44.6xFY2026 32.7xFY2026
EPS, next fiscal year $7.91FY2026 $15.78FY2026 $4.73FY2026
EPS growth, next FY +5.0%FY2026 +20.6%FY2026 -1.3%FY2026
EPS growth, the year after +23.4% +12.3% +10.4%
Revenue, next fiscal year $17.28BFY2026 $5.03BFY2026 $930.21MFY2026
Revenue growth, next FY +7.5%FY2026 +17.0%FY2026 +1.5%FY2026
Revenue growth, the year after +5.7% +0.4% +10.4%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersECLIDXXBMI
Held by institutions 80.0% 93.6% 100.0%
Institutions holding 1,715 1,292 481
Change in shares held, QoQ +1.4% +4.1% +7.9%
Institutions buying 764 590 253
Institutions selling 680 496 158
Buyers to sellers 1.12 1.19 1.60

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

ECLIDXXBMI
ECL 1.00 0.47 0.25
IDXX 0.47 1.00 0.23
BMI 0.25 0.23 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, ECL, IDXX and BMI?

Ecolab (ECL) is the largest by market capitalisation: Ecolab (ECL) $86.18B, Idexx Laboratories (IDXX) $55.47B, Badger Meter (BMI) $4.59B.

Which stock is cheaper, ECL, IDXX and BMI?

Badger Meter (BMI) trades on the lowest price-to-earnings ratio (Ecolab (ECL) 41.4x, Idexx Laboratories (IDXX) 46.9x, Badger Meter (BMI) 36.2x). On next year's consensus earnings, Badger Meter (BMI) is cheapest (Ecolab (ECL) 39.1x, Idexx Laboratories (IDXX) 44.6x, Badger Meter (BMI) 32.7x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Idexx Laboratories (IDXX) grew revenue fastest over the trailing twelve months: Ecolab (ECL) +9.3%, Idexx Laboratories (IDXX) +11.9%, Badger Meter (BMI) -2.2%.

Which company is more profitable?

Idexx Laboratories (IDXX) has the highest net margin (Ecolab (ECL) 12.0%, Idexx Laboratories (IDXX) 25.4%, Badger Meter (BMI) 14.4%). On return on invested capital, Idexx Laboratories (IDXX) leads (Ecolab (ECL) 10.0%, Idexx Laboratories (IDXX) 45.4%).

Which stock has performed better?

Over the past year Ecolab (ECL) returned the most: Ecolab (ECL) +18.0%, Idexx Laboratories (IDXX) +0.4%, Badger Meter (BMI) -12.9%. Over five years, Badger Meter (BMI) compounded fastest (Ecolab (ECL) +5.6%/yr, Idexx Laboratories (IDXX) +2.3%/yr, Badger Meter (BMI) +7.2%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Badger Meter (BMI) has the highest dividend yield: Ecolab (ECL) 0.01%, Idexx Laboratories (IDXX) 0.00%, Badger Meter (BMI) 0.01%. Idexx Laboratories (IDXX) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Ecolab (ECL) has been the steadiest (Ecolab (ECL) 21.8%, Idexx Laboratories (IDXX) 36.2%, Badger Meter (BMI) 50.9%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, ECL, IDXX and BMI?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Idexx Laboratories (IDXX) leads on 5. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.